BDO Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

BDO Wealth Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$114K	Buy	1,314 +43	+3%	+$4.05K	0.01%	325
2023 Q1	$124K	Hold	1,271	–	–	0.02%	301
2022 Q4	$132K	Hold	1,271	–	–	0.02%	302
2022 Q3	$108K	Hold	1,271	–	–	0.01%	319
2022 Q2	$105K	Buy	1,271 +60	+5%	+$4.78K	0.01%	318
2022 Q1	$93K	Sell	1,211 -18	-1%	-$1.51K	0.01%	346
2021 Q4	$109K	Buy	1,229 +18	+1%	+$1.49K	0.01%	344
2021 Q3	$94K	Hold	1,211	–	–	0.01%	360
2021 Q2	$101K	Buy	1,211 +11	+0.9%	+$872	0.01%	369
2021 Q1	$91K	Hold	1,200	–	–	0.01%	368
2020 Q4	$105K	Hold	1,200	–	–	0.01%	282
2020 Q3	$91K	Sell	1,200 -25	-2%	-$2.53K	0.01%	277
2020 Q2	$151K	Hold	1,225	–	–	0.03%	245
2020 Q1	$104K	Buy	1,225 +25	+2%	+$2.15K	0.02%	268
2019 Q4	$101K	Hold	1,200	–	–	0.03%	249
2019 Q3	$81K	Hold	1,200	–	–	0.02%	271
2019 Q2	$103K	Hold	1,200	–	–	0.03%	244
2019 Q1	$107K	Sell	1,200 -450	-27%	-$41.7K	0.03%	218
2018 Q4	$140K	Buy	1,650 +300	+22%	+$28.5K	0.05%	183
2018 Q3	$131K	Hold	1,350	–	–	0.04%	189
2018 Q2	$127K	Buy	+1,350	New	+$118K	0.04%	195

Other funds holding BMRN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BDO Wealth Advisors's BMRN Position: Q2 2023 in Review

BDO Wealth Advisors increased its BioMarin Pharmaceuticals (BMRN) stake by 3.4% in Q2 2023, buying an estimated $4.05K and bringing the position to 1,314 shares worth $114K. The position accounts for 0.01% of the portfolio, ranked #325.

BDO Wealth Advisors first reported a position in BMRN in Q2 2018 and has held it in 21 quarters since. The position peaked at $151K in Q2 2020. 558 funds tracked by Wall St. Rank hold BMRN as of Q2 2023.

BDO Wealth Advisors held 1,314 shares of BioMarin Pharmaceuticals worth $114K as of Q2 2023.
BDO Wealth Advisors bought 43 BioMarin Pharmaceuticals shares in Q2 2023, an estimated $4.05K.
BioMarin Pharmaceuticals made up 0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #325 holding.
BDO Wealth Advisors first reported a position in BioMarin Pharmaceuticals in Q2 2018 and has held it in 21 quarters since.
BDO Wealth Advisors's BioMarin Pharmaceuticals position peaked at $151K in Q2 2020.
558 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.